GENE ONLINE|News &
Opinion
Blog

Series B Funding
Series B Funding
China’s Qitan Technology Raises Over RMB400 Million in Series B Funding to Develop Nanopore Gene Sequencing
2021-06-23
Funding ecDNA
Boundless Bio Raises Fresh Capital to Boost extrachromosomal DNA Targeting Therapeutic Efforts
2021-04-30
Funding Cas9
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
Funding Viral Vector
North Carolina-Based Gene Therapy Startup Bags $81.5 Million in Series B Funding
2021-03-17
Funding oNK Cell Therapy
Acepodia Raises $47 Million Funding to Nurture its Next-Gen, oNK Cell Therapy Assets
2021-03-17
Startups Antibody
With $74 Million in Fresh Capital, Belgian Startup Aims to Advance its Regenerative Pathway Modulators
2021-03-11
Funding Cholesterol
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
Funding Gene Therapy
Tessera Raises $230M to Develop ‘Gene Writing’ into Novel Genetic Therapy
2021-01-15
Technology CRISPR
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Funding AI
Neuron23 Emerges from Stealth with $113.5 Million Financing
2020-12-18
Manufacturing
RESILIENCE Launches with an Aim to Overcome Limitations of Traditional Manufacturing
2020-11-25
Funding Solid Tumor
Elevation Oncology Raises $65 M to Repurpose Failed Drug for Genomically Defined Tumors
2020-11-20
Funding
Dewpoint Snags Successful Series B to Target Lesser Known Cellular Compartments
2020-10-02
1 2
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top